# Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital

> **NCT00321035** · PHASE3 · COMPLETED · sponsor: **Pro Top & Mediking Company Limited** · enrollment: 60 (estimated)

## Conditions studied

- Glaucoma
- Pterygium

## Interventions

- **DEVICE:** OculusGen Biodegradable Collagen Matrix Implant

## Key facts

- **NCT ID:** NCT00321035
- **Lead sponsor:** Pro Top & Mediking Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-01
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321035, "Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00321035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*